Anlon Healthcare Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 18.4%)
- Efficient capital deployment (ROCE 20.8%)
- Trading below book value (P/B 0.3x)
- Low debt relative to equity (D/E 0.2x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
AHCL · as of Jun 2026
| Category | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Promoters | 52.68% | 52.68% | 52.68% | 52.68% |
| FII | — | 0.23% | 0.32% | 1.67% |
| DII | 2.83% | 4.49% | 4.60% | 1.23% |
| Public | 44.49% | 42.60% | 42.40% | 44.43% |
Latest News
All newsAnlon Healthcare receives credit rating update
*Anlon Healthcare receives credit rating update.* The company has been assigned a credit rating as per a recent NSE filing. This reflects its current debt repayment capacity and financial health. The rating may influence investor sentiment and borrowing costs going forward. 📊 *STOCKS:* ANLONHEALTH | 🏢 *SECTOR:* Corporate | #LOWIMPACT #CreditRating
Anlon Healthcare reports Q1 FY27 financial results
*Anlon Healthcare reports Q1 FY27 financial results.* The company released its financial performance for the quarter ended June 30, 2026, via a press release filed on July 31, 2026. Key metrics such as **revenue**, **profit margins**, and **earnings per share** will be critical for trader sentiment. Market reaction will depend on whether results beat, missed, or met expectations. 📊 *STOCKS:* $ANLONHEALTH | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings
Anlon Healthcare reports Q1FY26 financial results
*Anlon Healthcare reports Q1FY26 financial results.* The company has filed its financial results for the quarter ended June 30, 2026. Details include revenue of **₹128.4 crore** and net profit of **₹9.2 crore**, marking a **14%** increase in profits year-on-year. Results reflect steady growth in domestic formulations business. 📊 *STOCKS:* $ANLONHEALTH | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Anlon Healthcare announces board meeting outcomes.
*Anlon Healthcare announces board meeting outcomes.* The company disclosed outcomes from its recent board meeting held on July 01, 2026. Details include routine corporate matters with no major financial implications. Specifics were not highlighted in the filing. 📊 *STOCKS:* ANLONHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #BoardMeeting
Anlon Healthcare acquires 63.98% stake in Remember India Health Links
*Anlon Healthcare acquires 63.98% stake in Remember India Health Links*\nAnlon Healthcare has completed the acquisition of a **63.98% equity stake** in Remember India Health Links Private Limited, marking a strategic expansion in the healthcare sector. The move strengthens Anlon’s footprint in health services and distribution. This acquisition is expected to enhance revenue streams and operational synergy.\n\n📊 *STOCKS:* ANLONHEALTH | 🏢 *SECTOR:* Corporate | #HIGHIMPACT #Acquisition
Anlon Healthcare to hold shareholder meeting on Sep 5, 2026
*Anlon Healthcare to hold shareholder meeting on Sep 5, 2026.* The meeting is scheduled for discussions on routine corporate matters. No **major** strategic announcements or financial updates were disclosed. Such events typically precede disclosures on dividends or board changes. 📊 *STOCKS:* $ANLONHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdersMeeting
Anlon Healthcare hosts analyst and investor meet.
*Anlon Healthcare hosts analyst and investor meet.* Company provided updates during its recent investor interaction. No major financial announcements or guidance changes were disclosed. The session focused on business operations and market outlook. 📊 *STOCKS:* $ANLONHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
Anlon Healthcare shares may react to investor presentation
*Anlon Healthcare shares may react to investor presentation.* The company released an investor presentation, likely outlining business strategy and financial highlights. Such filings typically provide strategic insights but lack immediate financial triggers. No major announcements or figures were disclosed. 📊 *STOCKS:* $ANLONHEALTH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorPresentation
Anlon Healthcare to host analyst and investor meet.
*Anlon Healthcare to host analyst and investor meet.* The company has announced a schedule for its upcoming analyst and institutional investor meet. This event aims to provide updates on business performance and strategic outlook. Specific financial details or major announcements were not disclosed. 📊 *STOCKS:* $ANLONHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
Anlon Healthcare Chairman to appear on Money TV
Anlon Healthcare's Chairman & Managing Director will be featured in an interview on Money TV. The segment may provide insights into the company’s strategy and operations. *Anlon Healthcare Chairman to appear on Money TV*. While not a material business update, it could influence retail sentiment. 📊 *STOCKS:* ANLONHEALTH | 🏢 *SECTOR:* Pharma | #LOWIMPACT #mediaappearance
About Anlon Healthcare Limited
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]
HealthcarePharmaceuticals & Biotechnology